Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7FFT | A0A0W3SG76 | The crystal structure of a domain-swapped dimeric maltodextrin-binding protein MalE from Salmonella enterica | |
| 7FF6 | P05413 | The 0.83 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with cis-vaccenic acid | |
| 7FET | P0DTC2 | SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer | |
| 7FEM | P0DTC2 | SARS-CoV-2 B.1.1.7 S-ACE2 complex | |
| 7FEM | Q9BYF1 | SARS-CoV-2 B.1.1.7 S-ACE2 complex | |
| 7FE4 | A5FBJ5 | Crystal structure of GH65 alpha-1,2-glucosidase from Flavobacterium johnsoniae in complex with glucose | |
| 7FE2 | A0A6N0WQ22 | Crystal structure of the mutant E494Q of GH92 alpha-1,2-mannosidase from Enterococcus faecalis ATCC 10100 in complex with alpha-1,2-mannobiose | |
| 7FE1 | A0A6N0WQ22 | Crystal structure of GH92 alpha-1,2-mannosidase from Enterococcus faecalis ATCC 10100 in complex with methyl alpha-1,2-C-mannobioside | |
| 7FDZ | G7LSK3 | Levansucrase from Brenneria sp. EniD 312 with sucrose | |
| 7FDW | P24627 | Crystal structure of pepsin cleaved lactoferrin C-lobe at 2.28 A resolution | |
| 7FDK | Q8R0I0 | SARS-COV-2 Spike RBDMACSp36 binding to mACE2 | |
| 7FDK | P0DTC2 | SARS-COV-2 Spike RBDMACSp36 binding to mACE2 | |
| 7FDI | Q9BYF1 | SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | |
| 7FDI | P0DTC2 | SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | |
| 7FDH | Q9BYF1 | SARS-COV-2 Spike RBDMACSp25 binding to hACE2 | |
| 7FDH | P0DTC2 | SARS-COV-2 Spike RBDMACSp25 binding to hACE2 | |
| 7FDG | Q9BYF1 | SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | |
| 7FDG | P0DTC2 | SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | |
| 7FD9 | P41594 | Thermostabilised full length human mGluR5-5M with orthosteric antagonist, LY341495 | |
| 7FD8 | P41594 | Thermostabilised full length human mGluR5-5M bound with L-quisqualic acid | |
| 7FD2 | A0A1Z2R994 | Cryo-EM structure of an alphavirus, Getah virus | |
| 7FCQ | P0DTC2 | Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FCQ | 7FCQ | Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FCP | P0DTC2 | Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FCP | 7FCP | Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FCE | P0DTC2 | Structure of the SARS-CoV-2 A372T spike glycoprotein (closed) | |
| 7FCD | P0DTC2 | Structure of the SARS-CoV-2 A372T spike glycoprotein (open) | |
| 7FC6 | F6V9L3 | Crystal structure of SARS-CoV RBD and horse ACE2 | |
| 7FC6 | P59594 | Crystal structure of SARS-CoV RBD and horse ACE2 | |
| 7FC5 | F6V9L3 | Crystal structure of SARS-CoV-2 RBD and horse ACE2 | |
| 7FC5 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD and horse ACE2 | |
| 7FC3 | F6V9L3 | structure of NL63 receptor-binding domain complexed with horse ACE2 | |
| 7FC3 | Q6Q1S2 | structure of NL63 receptor-binding domain complexed with horse ACE2 | |
| 7FBS | P15389 | structure of a channel | |
| 7FBS | B7UCZ6 | structure of a channel | |
| 7FBP | P00748 | FXIIa-cMCoFx1 complex | |
| 7FBP | 7FBP | FXIIa-cMCoFx1 complex | |
| 7FBL | 7FBL | Thrombocorticin in complex with Ca2+ and mannose | |
| 7FBK | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6 | |
| 7FBK | 7FBK | Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6 | |
| 7FBJ | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 | |
| 7FBJ | 7FBJ | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 | |
| 7FAT | P0DTC2 | Structure Determination of the RBD-NB1A7 | |
| 7FAT | 7FAT | Structure Determination of the RBD-NB1A7 | |
| 7FAP | Q8I639 | Structure of VAR2CSA-CSA 3D7 | |
| 7FAH | C3W5S1 | Immune complex of head region of CA09 HA and neutralizing antibody 12H5 | |
| 7FAH | 7FAH | Immune complex of head region of CA09 HA and neutralizing antibody 12H5 | |
| 7FAE | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P36-5D2(state2) | |
| 7FAE | 7FAE | S protein of SARS-CoV-2 in complex bound with P36-5D2(state2) | |
| 7FA0 | A0A509GV09 | The crystal structure of VyPAL2-C214A, a dead mutant of VyPAL2 peptide asparaginyl ligase in form II |
